Abe, Masatoshi
Okubo, Yukari
Takahashi, Hidetoshi
Endo, Koki
Chaudhari, Siddharth
Deignan, Cynthia
Amouzadeh, Hamid
Hino, Ryosuke
Clinical trials referenced in this document:
Documents that mention this clinical trial
Consistent Efficacy of Apremilast in Patients with Psoriasis Regardless of Baseline Disease Severity or Special Area Involvement: Subgroup Analysis from PROMINENT
https://doi.org/10.1007/s13555-024-01179-z
Funding for this research was provided by:
Amgen Inc.
Article History
Received: 8 December 2023
Accepted: 30 April 2024
First Online: 27 May 2024
Declarations
:
: Masatoshi Abe: Celgene and Maruho – consultant, paid speaker, research grant, and/or participated in clinical trials. Yukari Okubo<b>:</b> Eisai, Maruho, Shiseido, and Torii – research grants; AbbVie, Amgen Inc., Boehringer Ingelheim, Bristol Myers Squibb, Celgene, Eisai, Eli Lilly, Janssen Pharma, Jimro, Kyowa Kirin, LEO Pharma, Maruho, Novartis Pharma, Pfizer, Sanofi, Sun Pharma, Taiho, Tanabe-Mitsubishi, Torii, and UCB – honoraria; AbbVie, Amgen, Boehringer Ingelheim, Bristol Myers Squibb, Celgene, Eli Lilly, Janssen Pharma, LEO Pharma, Maruho, Pfizer, Sun Pharma, and UCB – clinical trials. Hidetoshi Takahashi<b>:</b> AbbVie, Amgen Inc., Eli Lilly, Janssen, Kaken Pharmaceutical, Kyowa Kirin, LEO Pharma, Maruho, Mitsubishi Tanabe, Novartis, Sanofi, Sato Pharmaceutical, Sun Pharma, Taiho Pharmaceutical, Torii, and UCB – honoraria. Koki Endo: Nothing to disclose. Siddharth Chaudhari<b>:</b> Amgen K.K. – employment. Cynthia Deignan and Hamid Amouzadeh: Amgen Inc. – employees and stockholders. Ryosuke Hino: AbbVie, Amgen, Celgene, Eli Lilly, Janssen Pharma, Kyowa Kirin, LEO Pharma, Maruho, Novartis Pharma, Sanofi, Sun Pharma, Taiho, Tanabe-Mitsubishi, Torii Pharma, and UCB Pharma – honoraria; Amgen, Celgene, Eli Lilly, LEO Pharma, Maruho, Otsuka Pharma, and Sanofi – clinical trials.
: The study was approved by the institutional review board/ethics committee before commencement and conducted in compliance with Good Clinical Practice, the International Council for Harmonisation Guideline E6, the Declaration of Helsinki, and applicable regulatory requirements. Patients provided written informed consent before study-related procedures.